Results: MHE Question of the Week About Health Insurance Coverage of GLP-1s for Weight Loss
The results of this week’s poll about health insurance coverage of GLP-1s for weight loss.
This week, we asked our readers if they think health insurance should cover GLP-1s for weight loss.
The results are in, and a majority (63%) think health insurance should cover GLP-1s for weight loss.
Specifically, 36% of readers agreed that Medicare should offer coverage because doing so would encourage coverage by private insurers. In addition, just over a quarter of readers (27%) believe in coverage because so many people have obesity, and obesity is a major risk factor for many chronic healthcare conditions.
We want to know what you’re thinking! Every Monday morning, the editors of Managed Healthcare Executive are posing a question to our readers about a timely issue in U.S. healthcare. We collect your answer and post the results on Friday.
In this latest episode of Tuning In to the C-Suite podcast, Briana Contreras, an editor with MHE had the pleasure of meeting Loren McCaghy, director of consulting, health and consumer engagement and product insight at Accenture, to discuss the organization's latest report on U.S. consumers switching healthcare providers and insurance payers.
Listen
Study of New Orleans Neighborhoods, Time to Viral Suppression, Shows Long Shadow of Redlining
October 7th 2024People living with HIV in neighborhoods that had been redlined by federal housing officials had a longer time interval between HIV diagnosis and achievement of viral suppression, a marker of successful treatment and access to healthcare, according to findings published in JAMA Internal Medicine.
Read More
In our latest "Meet the Board" podcast episode, Managed Healthcare Executive Editors caught up with editorial advisory board member, Eric Hunter, CEO of CareOregon, to discuss a number of topics, one including the merger that never closed with SCAN Health Plan due to local opposition from Oregonians.
Listen
Key Patient Considerations for Use of Intravenous and Subcutaneous Therapies
October 7th 2024Jill Zouzoulas, M.D., of Tryon Medical Partners in Charlotte, North Carolina, and Jennifer Seminerio, M.D., of University of Southern Florida Health in Tampa, Florida, discussed the biologics and the pros and cons of the intravenous and subcutaneous delivery methods in Managed Healthcare Executive’s K-Cast video series.
Read More
